Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Follow-Up Questions
Champions Oncology Inc (CSBR) 的市盈率是多少?
Champions Oncology Inc 的市盈率是 19.8276
Champions Oncology Inc 的 CEO 是谁?
Dr. Ronnie Morris 是 Champions Oncology Inc 的 Chief Executive Officer,自 2010 加入公司。
CSBR 股票的价格表现如何?
CSBR 的当前价格为 6.69,在上个交易日 decreased 了 0.06%。
Champions Oncology Inc 的主要业务主题或行业是什么?
Champions Oncology Inc 属于 Life Sciences Tools & Services 行业,该板块是 Health Care